Biomarkers are essentially used to diagnose, manage and predict the diseases of all kinds. The presence of biomarkers is critical to pinpoint the infection or infectious disease at large. One such biomarker has been identified that can even predict death by pneumonia or sepsis for as long as 14 years ahead in time. The new study has hit the scientific and medical community this month.
One of the leading journals has published a study indicating the presence of a biomarker that would turn the tables on the prevention and management of infectious diseases. The scientists have studied a well-known biomarker GlycA used a risk predictor in cardiovascular diseases. It has been shown that GlycA is associated with chronic inflammation, due to microbial infection and can predict death from infections up to 14 years in future. Scientists studied the records of more than 10000 patients and…
